<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="829">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05150366</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A02663-36</org_study_id>
    <nct_id>NCT05150366</nct_id>
  </id_info>
  <brief_title>Impact of Percutaneous Closure of the Left Atrial on the Maximum Proto-diastolic Speed of the Mitral Ring Measured by Tissue Doppler (ACTIFER)</brief_title>
  <acronym>ACTIFER</acronym>
  <official_title>Impact of Percutaneous Closure of the Left Atrial on the Maximum Proto-diastolic Speed of the Mitral Ring Measured by Tissue Doppler</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramsay Générale de Santé</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Clinical Trial Experts Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ramsay Générale de Santé</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to demonstrate the equivalence, before and after the percutaneous&#xD;
      closure of the left atrial procedure, of the maximum proto-diastolic velocity of the lateral&#xD;
      mitral annulus (e 'lat) measured by tissue Doppler. Patients with AF at high embolic risk and&#xD;
      presenting a formal and definitive contraindication to anticoagulants having been operated on&#xD;
      for percutaneous closure of the left atrial by St Jude AMULET device, considering an&#xD;
      equivalence margin of 1 cm / sec.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 17, 2021</start_date>
  <completion_date type="Anticipated">September 17, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 17, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>lateral e' speed</measure>
    <time_frame>1 day</time_frame>
    <description>measured by tissue Doppler</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Tissue Doppler</condition>
  <condition>Left Atrial Closure</condition>
  <arm_group>
    <arm_group_label>Patient scheduled for percutaneous closure of the left auricle by St Jude AMULET device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Trans thoracic echocardiography</intervention_name>
    <description>trans thoracic echocardiography at the beggining and at the end of the placement of the Saint Jude Medical AMULET type prosthesis</description>
    <arm_group_label>Patient scheduled for percutaneous closure of the left auricle by St Jude AMULET device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Man or woman over 18 years-old&#xD;
&#xD;
          -  Patient with paroxysmal AF at high embolic risk (CHA2DS2Vasc score ≥ 4) and presenting&#xD;
             a formal and definitive contraindication to anticoagulants&#xD;
&#xD;
          -  Patient scheduled for percutaneous closure of the left auricle by St Jude AMULET&#xD;
             device&#xD;
&#xD;
          -  Patient in sinus rhythm&#xD;
&#xD;
          -  Subject affiliated or beneficiary of a social security scheme&#xD;
&#xD;
          -  Patient having signed the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient participating in another clinical study&#xD;
&#xD;
          -  Patient in permanent ACFA&#xD;
&#xD;
          -  Patient with a mitral prosthesis (biological or mechanical),&#xD;
&#xD;
          -  Patient with a history of mitral annuloplasty&#xD;
&#xD;
          -  Protected patient: adult under guardianship, curatorship or other legal protection,&#xD;
             deprived of liberty by judicial or administrative decision;&#xD;
&#xD;
          -  Pregnant, breastfeeding or parturient woman;&#xD;
&#xD;
          -  Patient hospitalized without consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-François Oudet</last_name>
    <phone>0683346567</phone>
    <email>jf.oudet@ecten.eu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Hélène Barba</last_name>
    <email>mh.barba@ecten.eu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Privé Le Bois</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-François Oudet</last_name>
      <phone>0683346567</phone>
      <email>jf.oudet@ecten.eu</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 25, 2021</study_first_submitted>
  <study_first_submitted_qc>November 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2021</study_first_posted>
  <last_update_submitted>November 25, 2021</last_update_submitted>
  <last_update_submitted_qc>November 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

